Skip to main content
Screener/Healthcare/Biotechnology

CMPX Compass Therapeutics, Inc.

NASDAQ
$1.75-3.29 (-65.51%)
$1.61
$6.88
$1.61
$2.48
EPS (TTM)$-0.45
P/E Ratio
Dividend Yield
Market Cap$695.6M
Volume152.31M
Prev Close$5.03
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q4 '25$0-$15.7M$-0.09
Q3 '25$0-$14.3M$-0.10
Q2 '25$0-$19.9M$-0.14
Q1 '25$0-$16.6M$-0.12
Q4 '24$0-$15.0M$-0.11
Q3 '24$0-$10.5M$-0.08
Q2 '24$850K-$13.1M$-0.10100.0%-1538.4%
Q1 '24$0-$10.8M$-0.08
Get Your Daily Market Recap